News Article | December 10, 2016
Healthcare Real Estate Insights™ magazine has announced the Winners of the 2016 HREI Insights Awards™, the only national awards totally dedicated to recognizing excellence in the areas of healthcare real estate (HRE) development and executive leadership. The 2016 awards were presented today in nine different categories during the RealShare Healthcare Real Estate Conference in Scottsdale, Ariz. The awards were presented by Healthcare Real Estate Insights™, the first and only national magazine entirely devoted to covering healthcare real estate (HRE) development, financing and investment. HREI™ Publisher Murray Wolf noted, “The HREI Insights Awards™ have honored the best of the best in healthcare real estate since 2013.Yet we never fail to be astounded by the quality of the people and projects that are nominated. The projects that are submitted demonstrate the remarkable persistence and creativity of the development teams behind them. The development process is complicated and fraught with challenges. Yet, year after year, we receive dozens of entries demonstrating the amazing vision, creativity and hard work of the people in the healthcare real estate sector. The same goes for the individual awards. We are proud that this has become a very prestigious program with sought-after awards.” Sponsors of the 2016 HREI Insights Awards are: The 2016 Winners and Finalists will be featured in upcoming editions of Healthcare Real Estate Insights™ magazine, the 2017 HREI Resource Guide™ and on HREInsights.com. Best New Medical Office Building and Other Outpatient Facilities (Less than 25,000 square feet): Five Star ER, Pflugerville, Texas Developer: Lockard Lockard Emergency Service Partners had identified an optimal site in Pflugerville, an Austin, Texas, suburb, for its next freestanding emergency room under its Five Star ER brand. However, because the overall development plan had not been finalized, the lot needed for the project could not be sold individually. Lockard stepped in and worked directly with the land developer to finalize the development plan and expedite approval of other aspects of the agreement and process. In doing so, the company avoided costly delays. Construction on the 9,960 square foot facility got underway in March 2015 and was completed in October 2015. Best New Medical Office Building and Other Outpatient Facilities (25,000 to 49,999 square feet): Buck Creek Medical Plaza, Avon, Colo. Developer: NexCore Group LLC Colorado Mountain Medical needed to expand its service offerings in a new, centralized location with more parking. In a market with few buildable lots, NexCore found a 2.15-acre site in Avon that fit the bill. But there were challenges to overcome, and NexCore eventually acquired an adjacent lot and swapped parcels with the local fire district. Fast-tracking the project, NexCore opened the 48,300 square foot Buck Creek Medical Plaza in summer 2016. The company recruited Centennial, Colo.-based Centura Health as the emergency care anchor as well as a vibrant mix of providers to bring occupancy to 94 percent at the opening. Best New Medical Office Building and Other Outpatient Facilities (50,000 to 99,999 square feet): Penn Medicine Southern Chester County, West Grove, Penn. Developer: Anchor Health Properties Chester County Hospital wanted to grow its market share in the southernmost portion of its service area in Chester County and to position itself to deliver needed services well into the future. So the hospital sought to consolidate and expand services in a comprehensive new facility. Anchor Health Properties identified and then controlled a strategic, highly visible site and developed a 72,000 square foot “one-stop” healthcare destination. The MOB was fully occupied when it opened in summer 2015. Penn Medicine exceeded patient volume projections by 20 percent in Year 1 and increased outpatient registrations by 40 percent. Best New Medical Office Building and Other Outpatient Facilities (100,000 square feet or more): Hoag Health Center-Irvine-Sand Canyon, Irvine, Calif. Developer: PMB The Hoag Memorial system wanted to develop an outpatient facility adjacent to its Hoag Hospital Irvine to meet the healthcare needs of the rapidly growing area. The development team faced numerous challenges, including high voltage overhead power lines and underground issues, plus they wanted to link the MOB to the hospital with fiber-optic cable installed under a busy six-lane road. The team was able to deliver the 157,200 square foot facility below budget and on schedule. The facility was fully leased upon opening and is expected to achieve LEED Silver designation. Best Renovated or Repurposed Healthcare Facility: Clara Maass Medical Center MOBs, Belleville, N.J. Developer: Rendina Healthcare Real Estate Clara Maass Medical Center (CMMC) needed to significantly improve the condition of three MOBs on its campus and enhance the satisfaction of the tenant physicians. Rendina acquired the three buildings totaling 128,006 square feet and completely modernized and renovated all common areas. They also added new building systems, signage, wayfinding, artwork, furniture and handicap parking improvements. Since Rendina took ownership, occupancy has increased nearly 10 percent, many physician groups have shifted from short-term commitments to long-term leases, and overall satisfaction has increased 7 percent. Hospitals and Other Inpatient Facilities – Best New Ground-Up Development: TriHealth Bethesda Butler Hospital, Hamilton, Ohio Developer: Duke Realty TriHealth wanted to enter a Cincinnati sub-market and employ a physician practice that owned a six-building hospital campus. TriHealth needed to immediately add an ED and lab and in the future additional beds to accommodate its growing patient base. The development team orchestrated a four-phase expansion to minimize disruptions to the hospital’s daily operations. The expanded 90,788 square foot facility has enabled TriHealth to add more services, physicians and staff; treat more patients; and have room for future growth. It’s also helping it be more competitive in the Cincinnati market and serve as a convenient, full-service campus. Finalists Advocate Christ Medical Center, East Patient Tower, Oak Lawn, IL Advocate Health Care Scripps Networks Tower at E. Tenn. Children’s Hospital, Knoxville, TN Realty Trust Group Sibley Memorial Hospital New Patient Tower, Washington D.C. Sibley Memorial Hospital Zuckerberg San Francisco General Hospital and Trauma Center, S.F. San Francisco Health Network Post-Acute & Senior Living Facilities – Best New Ground-Up Development: Beach House Assisted Living and Memory Care, Naples, Fla. Developer: Prevarian Companies LP It has taken more than a decade for the site at 1000 Airport Pulling Road S. in Naples to finally be developed after years of delays caused by a long entitlement process and the recession. Making the project a reality was Prevarian, which started pursuing a development on the site just two years prior to opening the 113-unit Beach House Assisted Living and Memory Care community. The company had to make sure the design conformed to a previously approved footprint and site plan, and it received permits within four months of securing the land. Beach House is close to a shopping district and a community hospital. Healthcare Real Estate Executive of the Year: Jason Signor, Caddis Under Jason Signor’s leadership, Caddis has grown from seven employees to 47 and become an industry-leading, full-service developer, owner and property manager of MOBs, ASCs, hospitals and, under its Heartis brand, senior living communities. With offices in Dallas, Atlanta, Houston and Phoenix, the firm has developed and/or acquired more than 40 assets with a total value of more than $700 million spanning 2.7 million square feet of space and 1,500 beds. Caddis has deployed $150 million of equity and manages about 3 million square feet in seven states. During his time with Caddis, Mr. Signor also has spurred the creation of a proprietary, GIS mapping interface used for identifying market opportunities and allowing clients to make informed, evidence-based site selection decisions. Tim Oliver’s legacy includes being involved in the development and consulting engagements for more than 90 facilities totaling 5 million square feet in the past 40-plus years. Mr. Oliver has focused exclusively on medical real estate since 1974 and has cofounded several firms. Tim Oliver and John McWilliams were involved in the formation of Western Skies (WSI) in 1970, and led the company’s development of its first on-campus MOB in 1975. At the time, the concept of on-campus medical office buildings was in its infancy. WSI developed the second on-campus MOB in the Rocky Mountain region for Mercy Hospital. Over the next 16 years, WSI developed 1.5 million square feet of ambulatory facilities and managed over 1 million square feet of healthcare properties. In 1986, Tim was one of the original founders of Integrated Medical Campus, providing strategic planning/development services for over 50 medical projects. In 1987, IMC developed one of the nation’s first “medical mall” or “hospital without beds” projects that featured a freestanding emergency department, ambulatory surgery center, imaging, physical therapy and medical offices. In 2004, Mr. Oliver joined five other founders from The Neenan Company to form the Denver-based NexCore Group. To date, NexCore Group has developed and acquired 6.5 million square feet of real estate, executed leases totaling 3.5 million square feet, and now has 65 employees in seven offices across the United States. Today, Mr. Oliver is actively training the next generation of strategic-thinking development executives at NexCore Group. He has been a thought leader at NexCore, responsible for understanding the legislative and economic environment, best practices in the delivery of care, and population health management/wellness initiatives that affect the development of healthcare real estate. His strategic thinking continues to provide top-of-class service to NexCore’s national healthcare clients. Launched in 2003, HREI was the first and remains the only national magazine entirely dedicated to covering healthcare real estate development, financing and investment. This monthly, national, business-to-business magazine offers sophisticated players the most comprehensive coverage in the industry available anywhere. Introduced in 2008, the HREI Resource Guide was the first and is still the only annual directory of healthcare real estate services. And HREI’s companion website, HREInsights.com, has been totally redesigned and vastly expanded with more than 10 years of content, more than 2,000 articles and nearly 2 million words of copy, becoming the new hub for healthcare real estate news and information. For more information on HREI products and services, or to subscribe or advertise, please visit us at HREInsights.com.
News Article | October 28, 2016
The International Association of HealthCare Professionals is pleased to welcome Martins A. Adeoye, MD, Psychiatrist, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. He is a highly trained and qualified psychiatrist with a vast expertise in all facets of his work. Dr. Adeoye has been in practice for more than 24 years and is currently serving patients as a Psychiatrist at the Elemental Center For Personal Development. Furthermore, he is affiliated with the University of Illinois Hospital Medical Center, Edward Hospital, Advocate Christ Medical Center, the Little Company of Mary Hospital, and Linden Oaks Hospital. Dr. Adeoye gained his Medical Degree in 1992 from the University of Ibadan in Nigeria. After moving to the United States, an internship was completed at the University of Illinois. Dr. Adeoye remained at this University to complete his residency in Psychiatry, where he served as Chief Resident, followed by his fellowship in Child and Adolescent Psychiatry. Dr. Adeoye holds dual board certification in both Psychiatry and in Child and Adolescent Psychiatry, and is recognized as an expert in the management and treatment of autism and mood disorders. He maintains professional memberships with the American Psychiatric Association, the American Academy of Clinical Psychiatrists, and the Academy of Clinical and Applied Psychoanalysis. Dr. Adeoye attributes his success to being diligent and focused, with a desire to help people. When he is not working, he enjoys traveling and photography. Learn more about Dr. Adeoye by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics. Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review. FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise. A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life. For more information about FindaTopDoc, visit http://www.findatopdoc.com
News Article | November 10, 2016
Oak Lawn is committed to making everyone who moves there an immediate part of their community! The Top 15 reasons to choose Oak Lawn as home: 1. Choice of private/public schools within and bordering the Village, from pre-school to higher education. 2. Benefit from Advocate Christ Medical Center, Children’s Hospital, and Ronald McDonald House which are all recipients of the Magnet Award for Excellence in Nursing Services. 3. Benefit from proximity to world-class downtown Chicago and Lake Michigan waterfront. 5. Enjoy a mature tree canopy and neighborhoods with Oak-lined parkways, nearby open space, and a park system. 6. Experience a unique sense of community and stability, where residents stay and second generations return. 7. Use centrally located library with a contemporary catalog of items. 8. Dine in front porch atmosphere with outdoor seating and restaurant gardens prevalent in the community. 12. Feel safe with a Class One fire-rescue department, that puts Oak Lawn in the top 5% of nation and the 12th to be designated in the nation. 13. Feel safe with low crime rates and a police force committed to neighborhood policing. 14. Strong, well maintained housing stock with no bad neighborhoods. 15. Recreate with the Oak Lawn Park District: active recreation play fields, indoor basketball, ice rink, tennis courts, and cutting edge cultural arts program for all ages. Key Realty’s Managing Broker Patrick OConnell can help clients with their property search in Oak Lawn, or anywhere throughout the Chicago land area! A local guy, Patrick grew up in Chicago’s Beverly Neighborhood. He started a mortgage brokerage company called Proficient Financial Services and acquired his real estate license. For the last 10 years he has solely focused on his real estate business. OConnell is an expert agent in the Chicago Metropolitan area where his mortgage and marketing background is a valuable asset for clients to help them find a home that is right for them. Being from Chicago, he brings knowledge and expertise about buying and selling real estate in the area. Key Realty highlights OConnell’s experience as someone who knows the Chicago Metropolitan area inside and out with strong negotiating skills. It says he has an understanding of the area including all neighborhood amenities along with essential criteria for which clients are looking. More information about Key Realty and other Oak Lawn real estate listings are available at buypropertyright.com For more information, please visit http://www.buypropertyright.com
Collins Y.,Advocate Christ Medical Center |
Holcomb K.,New York Medical College |
Chapman-Davis E.,Tufts University |
Khabele D.,Vanderbilt University |
Farley J.H.,Arizona Cancer Center
Gynecologic Oncology | Year: 2014
Objectives To review the extent of health disparities in gynecologic cancer care and outcomes and to propose recommendations to help counteract the disparities. Methods We searched the electronic databases PubMed and the Cochrane Library. We included studies demonstrating quantifiable differences by race and ethnicity in the incidence, treatment, and survival of gynecologic cancers in the United States (US). Most studies relied on retrospective data. We focused on differences between Black and White women, because of the limited number of studies on non-Black women. Results White women have a higher incidence of ovarian cancer compared to Black women. However, the all-cause ovarian cancer mortality in Black women is 1.3 times higher than that of White women. Endometrial and cervical cancer mortality in Black women is twice that of White women. The etiology of these disparities is multifaceted. However, much of the evidence suggests that equal care leads to equal outcomes for Black women diagnosed with gynecologic cancers. Underlying molecular factors may play an additional role in aggressive tumor biology and endometrial cancer disparities. Conclusion Gynecologic cancer disparities exist between Black and White women. The literature is limited by the lack of large prospective trials and adequate numbers of non-Black racial and ethnic groups. We conclude with recommendations for continued research and a multifaceted approach to eliminate gynecologic cancer disparities. © 2014 Elsevier Inc.
Cowger J.,University of Michigan |
Sundareswaran K.,Thoratec Corporation |
Rogers J.G.,Duke University |
Park S.J.,Mayo Medical School |
And 5 more authors.
Journal of the American College of Cardiology | Year: 2013
Objectives: The aim of this study was to derive and validate a model to predict survival in candidates for HeartMate II (HMII) (Thoratec, Pleasanton, California) left ventricular assist device (LVAD) support. Background: LVAD mortality risk prediction is important for candidate selection and communicating expectations to patients and clinicians. With the evolution of LVAD support, prior risk prediction models have become less valid. Methods: Patients enrolled into the HMII bridge to transplantation and destination therapy trials (N = 1,122) were randomly divided into derivation (DC) (n = 583) and validation cohorts (VC) (n = 539). Pre-operative candidate predictors of 90-day mortality were examined in the DC with logistic regression, from which the HMII Risk Score (HMRS) was derived. The HMRS was then applied to the VC. Results: There were 149 (13%) deaths within 90 days. In the DC, mortality (n = 80) was higher in older patients (odds ratio [OR]: 1.3, 95% confidence interval [CI]: 1.1 to 1.7 per 10 years), those with greater hypoalbuminemia (OR: 0.49, 95% CI: 0.31 to 0.76 per mg/dl of albumin), renal dysfunction (OR: 2.1, 95% CI: 1.4 to 3.2 per mg/dl creatinine), coagulopathy (OR: 3.1, 95% CI: 1.7 to 5.8 per international normalized ratio unit), and in those receiving LVAD support at less experienced centers (OR: 2.2, 95% CI: 1.2 to 4.4 for <15 trial patients). Mortality in the DC low, medium, and high HMRS groups was 4%, 16%, and 29%, respectively (p < 0.001). In the VC, corresponding mortality was 8%, 11%, and 25%, respectively (p < 0.001). HMRS discrimination was good (area under the receiver-operating characteristic curve: 0.71, 95% CI: 0.66 to 0.75). Conclusions: The HMRS might be useful for mortality risk stratification in HMII candidates and may serve as an additional tool in the patient selection process. © 2013 American College of Cardiology Foundation.
Park S.J.,Mayo Medical School |
Milano C.A.,Duke University |
Tatooles A.J.,Advocate Christ Medical Center |
Rogers J.G.,Duke University |
And 3 more authors.
Circulation: Heart Failure | Year: 2012
Background-The HeartMate II (HMII) destination therapy (DT) trial demonstrated significant improvements in outcomes in continuous-flow left ventricular assist devices compared with patients implanted with the pulsatile-flow HeartMate XVE. The primary hypothesis of the current study is that trial patients enrolled after the initial data cohort would have better clinical outcomes. Methods and Results-Two hundred eighty-one patients who underwent HMII for DT from May 2007 to March 2009 (Mid Trial [MT] group) were compared with the initial 133 HMII patients from March 2005 to May 2007 (Early Trial [ET] group). Patient entry criteria were the same during the 2 time periods. Survival, adverse events, and quality of life were compared between the 2 groups. Baseline characteristics were similar between the groups. Compared with the ET group, patients in the MT group had reduced adverse event rates for bleeding requiring transfusions (1.66 versus 1.13 events per patient-year, P<0.001), sepsis (0.38 versus 0.27, P=0.025), device-related infections (0.47 versus 0.27, P<0.001), and hemorrhagic stroke (0.07 versus 0.03, P=0.01). Other event rates were similar between groups including ischemic stroke (0.06 versus 0.05 events per patient-year, P=0.57). Survival at 1 year in the MT group was 73% versus 68% in the ET group (P=0.21). Additionally, there was a significant reduction in deaths caused by hemorrhagic stroke (P=0.01). Quality of life improvements were significant in both the groups (P<0.001). Conclusions-The benefit of DT therapy with the HMII is confirmed in subsequent trial patients, with improved adverse event rates and a strong trend for improvements in survival. Clinical Trial Registration-URL: http://www. clinicaltrials.gov. Unique identifier: NCT00121485. © 2012 American Heart Association, Inc.
Kurien S.,Advocate Christ Medical Center |
Hughes K.A.,Advocate Christ Medical Center
AACN Advanced Critical Care | Year: 2012
A left ventricular assist device (LVAD) is a lifesaving therapy for end-stage heart failure, but it is associated with major complications such as bleeding and thrombosis. Anticoagulation is an important part of LVAD therapy; it requires meticulous management and monitoring for prevention of thromboembolic and bleeding events. Recommendations for thromboprophylaxis vary among pulsatile and nonpulsatile devices and require multiple pharmacological agents to achieve adequate anticoagulation. Patients expected to undergo LVAD implantation must have a comprehensive evaluation for underlying coagulopathies. During the perioperative period, all measures must be taken to prevent excessive bleeding and maintain hemostasis. Postoperative bleeding and thromboembolic episodes must be minimized to prevent significant complications of ventricular assist device therapy. Bleeding and thromboembolism are an impediment to a patient's quality of life as they can result in multiple hospitalizations, along with serious consequences such as death and permanent disability. Copyright © 2012 American Association of Critical-Care Nurses.
Kannankeril A.J.,Advocate Christ Medical Center
Urologic nursing | Year: 2011
Clean intermittent catheterization used to manage urinary retention can be complicated by urinary tract infection (UTI). This retrospective study describes the frequency of antibiotic-treated UTI in patients undergoing intermittent catheterization. Most patients did not have UTI; this supports findings in previous studies.
Hummel P.,Loyola University |
Lawlor-Klean P.,Advocate Christ Medical Center |
Weiss M.G.,Loyola University
Journal of Perinatology | Year: 2010
Objective: To establish evidence of clinical validity and reliability of the Neonatal Pain, Agitation, and Sedation Scale (N-PASS) in neonates with acute heelstick pain. Study Design: Prospective psychometric evaluation, randomized crossover design. Two nurses administered the N-PASS simultaneously and independently during an actual and sham heelstick done in randomized order. One nurse also administered the Premature Infant Pain Profile (PIPP) concurrently with the N-PASS. Heelsticks were videotaped for repeat analysis. Result: Construct (discriminate) validity was established through the Wilcoxon Signed-ranks test, comparing the distribution of the heelstick and sham N-PASS scores. The mean pain scores were 3.93 (2.30) and 0.81 (1.21) for the heelstick and sham procedures, respectively (Z=-6.429, P<0.0001). Convergent validity was demonstrated by correlation with the PIPP scores (Spearman rank correlation coefficient of 0.75 and 0.72 for raters 1 and 2, respectively). Inter-rater reliability was high, measured by intra-class coefficients; the ICC estimates (95% CI) of the pain scale were 0.86 (0.78, 0.92) and 0.93 (0.88, 0.96) for a single rating and average of two independent ratings, respectively (P<0.0001). Internal consistency, measured by Cronbach's alpha, was evident (0.84 to 0.89). Test-retest reliability was demonstrated by repeat scoring of videotaped heelsticks, measured by Spearman's rho correlation (0.874, P<0.0001). Conclusion: This research provides beginning evidence that the N-PASS is a valid and reliable tool for assessing acute heelstick pain in infants 0 to 30 days of age, 23 to 40 weeks gestation. © 2010 Nature America, Inc. All rights reserved.
Nouh A.,Loyola University Chicago |
Remke J.,Advocate Christ Medical Center |
Ruland S.,Loyola University Chicago
Frontiers in Neurology | Year: 2014
Posterior circulation strokes represent approximately 20% of all ischemic strokes (1, 2). In contrast to the anterior circulation, several differences in presenting symptoms, clinical evaluation, diagnostic testing, and management strategy exist presenting a challenge to the treating physician. This review will discuss the anatomical, etiological, and clinical classification of PC strokes, identify diagnostic pitfalls, and overview current therapeutic regimens. © 2014 Nouh, Remke and Ruland.